Aurubis AG
OTC:AIAGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aurubis AG
OTC:AIAGF
|
DE |
|
E
|
Enel SpA
XMUN:ENL
|
IT |
|
Capcom Co Ltd
TSE:9697
|
JP |
|
Excelerate Energy Inc
NYSE:EE
|
US |
|
Avcorp Industries Inc
TSX:AVP
|
CA |
|
Fresh Del Monte Produce Inc
NYSE:FDP
|
US |
|
Indusind Bank Ltd
BSE:532187
|
IN |
|
Tyra Biosciences Inc
NASDAQ:TYRA
|
US |
|
Summit Therapeutics Inc
NASDAQ:SMMT
|
US |
|
N
|
NewAmsterdam Pharma Company NV
F:KH6
|
NL |
|
Taylor Devices Inc
NASDAQ:TAYD
|
US |
|
Pro Medicus Ltd
ASX:PME
|
AU |
|
C
|
Clean Energy Fuels Corp
XMUN:WIQ
|
US |
Wall St Price Targets
AIAGF Price Targets Summary
Aurubis AG
According to Wall Street analysts, the average 1-year price target for AIAGF is 171.24 USD with a low forecast of 108.39 USD and a high forecast of 225.37 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AIAGF's stock price target?
Price Target
171.24
USD
According to Wall Street analysts, the average 1-year price target for AIAGF is 171.24 USD with a low forecast of 108.39 USD and a high forecast of 225.37 USD.